Description
CJC-1295 without DAC is a synthetic analog of growth hormone-releasing hormone (GHRH),while Ipamorelin is a selective growth hormone secretagogue that mimics ghrelin activity.Together, they act on different receptors to stimulate natural growth hormone release from thepituitary gland. This combination is frequently studied for its synergistic effects on growthhormone signaling pathways, offering controlled stimulation while maintaining physiologicalhormone patterns. The absence of DAC results in a shorter half-life compared to DAC-modifiedversions, allowing for more precise timing in experimental protocols. This peptide combination iswidely used in research focused on endocrine signaling, metabolic regulation, and tissueregeneration pathways.
